What are the considerations for anticoagulant therapy in patients with sickle cell anemia, and how does it affect their thrombotic and bleeding risks?
Gaurav ChauhanContributor
IVF Questions & Answers
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
What are the considerations for anticoagulant therapy in patients with sickle cell anemia, and how does it affect their thrombotic and bleeding risks?
Patients with sickle cell anemia face increased thrombotic risk due to blood cell abnormalities, yet are also at risk for bleeding due to potential blood vessel damage. Anticoagulant therapy must be carefully balanced to manage both risks.